Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Epizyme Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

30 Apr 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Epizyme Inc (EPZM-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

29 Apr 2016 Thomson Reuters Stock Report 12 $25.00

ValuEngine Rating and Forecast Report for EPZM

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

24 Apr 2016 ValuEngine, Inc. 11 $25.00

EPIZYME INC (EPZM=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

23 Apr 2016 Pechala's Reports 2 $25.00

Value Graph: EPIZYME -- EPZM

22 Apr 2016 Ford Investor Services, Inc. 1 $12.00

EpiZyme, Inc. (EPZM) - Financial Analysis Review

EpiZyme, Inc. (EPZM) - Financial Analysis Review Summary EpiZyme, Inc. (Epizyme) is a biopharmaceutical company that discover...

19 Apr 2016 GlobalData 54 $300.00

Wright Investors Service Comprehensive Report for Epizyme Inc

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

10 Apr 2016 Wright Reports 54 $75.00

EpiZyme, Inc. (EPZM) - Financial Analysis Review

EpiZyme, Inc. (EPZM) - Financial Analysis Review Summary EpiZyme, Inc. (Epizyme) is a biopharmaceutical company that discover...

17 Mar 2016 GlobalData 54 $300.00

EPZM.OQ - Event Transcript of Epizyme Inc conference call, Mar. 09, 2016 / 8:00AM ET

Edited Event Transcript of EPZM.OQ conference call, Mar. 09, 2016 / 8:00AM ET Boston, Apr 1, 2016 (Thomson StreetEvents...

09 Mar 2016 Thomson Reuters StreetEvents 11 $75.00

EpiZyme, Inc. (EPZM) - Financial Analysis Review

EpiZyme, Inc. (EPZM) - Financial Analysis Review Summary EpiZyme, Inc. (Epizyme) is a biopharmaceutical company that discover...

02 Dec 2015 GlobalData 54 $300.00